Aemetis (AMTX) Q4 2024 earnings summary

Executive summary

• Annual revenues rose 43% to $268 million in 2024, with growth across all business segments, driven by increased production and favorable policy support for renewable fuels.

• India biodiesel revenues increased 20% to $93 million; California ethanol revenues up 55% to $162 million.

• Aemetis Biogas annual revenues surged 139%, with production capacity up 80%.

• Net loss for 2024 was $87.5 million, compared to $46.4 million in 2023.

• Major operational milestones included solar microgrid installation, LCFS credit sales, and new air permits for SAF/renewable diesel plant.

Financial highlights

• 2024 revenues reached $268 million, up from $187 million in 2023, with all segments reporting increases.

• Gross loss of $580,000 in 2024 versus a gross profit of $2 million in 2023; dairy renewable natural gas segment contributed $5.4 million in gross profit.

• Operating loss widened to $40.4 million in 2024 from $37.4 million in 2023.

• Adjusted EBITDA for 2024 was negative $18.8 million, compared to negative $22.4 million in 2023.

• Cash at year-end 2024 was $898,000, down from $2.7 million at the end of 2023.

Outlook and guidance

• Anticipates further revenue and margin growth from new LCFS mandates, federal tax credits (45Z, 45Q, 48), and expanded E15 ethanol approvals.

• Expects LCFS credit prices to rise after regulatory delays are resolved, benefiting renewable fuel margins.

• India biodiesel IPO targeted for late 2025 or early 2026, contingent on new OMC tenders and market conditions.

• Biogas production capacity expected to reach 1 million MMBTU/year by 2026, with significant USDA-backed financing in process.

• Ongoing capital projects for carbon intensity reduction and biogas expansion expected to complete in 2025.